External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert, Stefan Michiels, Hugo Horlings, Kalliopi P. Siziopikou, Scott Ely, Dimitrios Zardavas, Roberts Mustimbo, John Bartlett, Giuseppe Floris, Johan Hartman, Carolien H.M. van Deurzen, Dorien Ceusters, Els Dequeker, Roberto Salgado*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

13 Downloads (Pure)

Abstract

New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

Original languageEnglish
Article number3762
JournalCancers
Volume14
Issue number15
DOIs
Publication statusPublished - 2 Aug 2022

Bibliographical note

Funding Information:
The training and EQC-platform have been supported by the Breast Cancer Research Foundation and Bristol-Myers Squib (CW3199227).

Publisher Copyright:
© 2022 by the authors.

Fingerprint

Dive into the research topics of 'External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices'. Together they form a unique fingerprint.

Cite this